Weekly Roundup: Givaudan reports dividend increase, Gencor’s Levagen gains muscle support evidence

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

A new Gencor study is touting its Levagen+ product, which contains palmitoylethanolamide (PEA), is a viable alternative to cannabidiol (CBD) – offering the same... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The maturation of the cannabidiol (CBD) market has led to a diversified array of applications for this functional ingredient, while experts are observing a rising demand... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Twenty-four sports companies have been awarded by the European Specialist Sports Nutrition Alliance (ESSNA) for “demonstrating resilience and innovation”... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Health claims play a crucial role in communicating with consumers but different regional approaches reveal a fractured scene. Experts from Gencor, Lonza,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé and the Friedman School of Nutrition Science and Policy at US-based Tufts University have launched the Global Nutrition and Health Atlas (GNHA), a new... Read More

trans